Citius Pharmaceuticals Inc. [NASDAQ: CTXR] traded at a high on 06/09/20, posting a 4.80 gain after which it closed the day’ session at $0.98. The results of the trading session contributed to over 2502703 shares changing hands. Over the past one week, the price volatility of Citius Pharmaceuticals Inc. stands at 8.92% while the volatility over the past one month is 8.86%.
The market cap for CTXR stock reached $44.54 million, with 34.32 million shares outstanding and 32.88 million shares in the current float. Compared to the average trading volume of 1.46M shares, CTXR reached a trading volume of 2502703 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.
What do top market gurus say about Citius Pharmaceuticals Inc. [CTXR]?
The Average True Range (ATR) for Citius Pharmaceuticals Inc. is set at 0.09 The Price to Book ratio for the last quarter was 1.51, with the Price to Cash per share for the same quarter was set at 0.09.
How has CTXR stock performed recently?
Citius Pharmaceuticals Inc. [CTXR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 8.62. With this latest performance, CTXR shares gained by 3.69% in over the last four-week period, additionally plugging by 107.17% over the last 6 months – not to mention a drop of -7.56% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CTXR stock in for the last two-week period is set at 59.71, with the RSI for the last a single of trading hit 61.35, and the three-weeks RSI is set at 57.24 for Citius Pharmaceuticals Inc. [CTXR]. The present Moving Average for the last 50 days of trading for this stock 0.8319, while it was recorded at 0.9640 for the last single week of trading, and 0.7791 for the last 200 days.
Citius Pharmaceuticals Inc. [CTXR]: Deeper insight into the fundamentals
Return on Total Capital for CTXR is now -59.32, given the latest momentum, and Return on Invested Capital for the company is -59.57. Return on Equity for this stock declined to -59.57, with Return on Assets sitting at -51.84. When it comes to the capital structure of this company, Citius Pharmaceuticals Inc. [CTXR] has a Total Debt to Total Equity ratio set at 0.71. Additionally, CTXR Total Debt to Total Capital is recorded at 0.70, with Total Debt to Total Assets ending up at 0.60.
Reflecting on the efficiency of the workforce at the company, Citius Pharmaceuticals Inc. [CTXR] managed to generate an average of -$1,729,127 per employee.Citius Pharmaceuticals Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 1.40.
Earnings analysis for Citius Pharmaceuticals Inc. [CTXR]
With the latest financial reports released by the company, Citius Pharmaceuticals Inc. posted -0.2/share EPS, while the average EPS was predicted by analysts to be reported at -0.2/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CTXR.
Insider trade positions for Citius Pharmaceuticals Inc. [CTXR]
There are presently around $2 million, or 12.00% of CTXR stock, in the hands of institutional investors. The top three institutional holders of CTXR stocks are: SABBY MANAGEMENT, LLC with ownership of 1,354,275, which is approximately New of the company’s market cap and around 39.08% of the total institutional ownership; VANGUARD GROUP INC, holding 464,406 shares of the stock with an approximate value of $0.43 million in CTXR stocks shares; and ARGENT WEALTH MANAGEMENT LLC, currently with $0.15 million in CTXR stock with ownership of nearly 0% of the company’s market capitalization.
6 institutional holders increased their position in Citius Pharmaceuticals Inc. [NASDAQ:CTXR] by around 1,491,760 shares. Additionally, 6 investors decreased positions by around 56,131 shares, while 4 investors held positions by with 589,530 shares. The mentioned changes placed institutional holdings at 2,137,421 shares, according to the latest SEC report filing. CTXR stock had 5 new institutional investments in for a total of 1,475,174 shares, while 5 institutional investors sold positions of 53,309 shares during the same period.